作者: Kaoru Tanaka , Kunio Okamoto , Kazuko Sakai , Toshio Shimizu , Kazuhiko Nakagawa
DOI:
关键词:
摘要: The present invention relates to a RET fusion gene such as CCDC6-RET biomarker monitor the activity of compound 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone or pharmaceutically acceptable salt thereof, and especially its monoethanesulphonate form, when used alone optionally in combination with further active ingredients and/or treatments. also specific uses said treatment cancers.